Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Collins

Showing results (171-180 of 247) with videos related to

Pageof 25
Sort By:
Journal of Virology|November 16, 2004
Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidateStéphane Biacchesi, Mario H Skiadopoulos, Lijuan Yang, et al.
Journal of Virology|March 5, 2010
Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infectionJames A Harker, Debbie C P Lee, Yuko Yamaguchi, et al.
Journal of Virology|August 24, 2007
Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virusJoshua M DiNapoli, Lijuan Yang, Amorsolo Suguitan, et al.
Journal of Virology|August 25, 2017
Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV FXiang Liu, Bo Liang, Joan Ngwuta, et al.
The Journal of Clinical Investigation|April 10, 2014
RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstructionRachael M Liesman, Ursula J Buchholz, Cindy L Luongo, et al.
Plos One|December 3, 2010
Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cellsCyril Le Nouën, Philippa Hillyer, Shirin Munir, et al.
Plos One|October 17, 2013
Evaluation of the replication, pathogenicity, and immunogenicity of avian paramyxovirus (APMV) serotypes 2, 3, 4, 5, 7, and 9 in rhesus macaquesSunil K Khattar, Baibaswata Nayak, Shin-Hee Kim, et al.
Vaccine|January 27, 2009
Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humansJoshua M DiNapoli, Jerrold M Ward, Lily Cheng, et al.
Molecular & Cellular Proteomics : MCP|August 10, 2014
A comprehensive proteomic view of responses of A549 type II alveolar epithelial cells to human respiratory syncytial virus infectionKeyur A Dave, Emma L Norris, Alexander A Bukreyev, et al.
Vaccine|October 28, 2009
A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidatesEmmalene J Bartlett, Ann-Marie Cruz, Jim Boonyaratanakornkit, et al.
Pageof 25

Showing results (171-180 of 247) with videos related to

Sort By:
Pageof 25
Journal of Virology|November 16, 2004
Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidateStéphane Biacchesi, Mario H Skiadopoulos, Lijuan Yang, et al.
Journal of Virology|March 5, 2010
Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infectionJames A Harker, Debbie C P Lee, Yuko Yamaguchi, et al.
Journal of Virology|August 24, 2007
Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virusJoshua M DiNapoli, Lijuan Yang, Amorsolo Suguitan, et al.
Journal of Virology|August 25, 2017
Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV FXiang Liu, Bo Liang, Joan Ngwuta, et al.
The Journal of Clinical Investigation|April 10, 2014
RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstructionRachael M Liesman, Ursula J Buchholz, Cindy L Luongo, et al.
Plos One|December 3, 2010
Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cellsCyril Le Nouën, Philippa Hillyer, Shirin Munir, et al.
Plos One|October 17, 2013
Evaluation of the replication, pathogenicity, and immunogenicity of avian paramyxovirus (APMV) serotypes 2, 3, 4, 5, 7, and 9 in rhesus macaquesSunil K Khattar, Baibaswata Nayak, Shin-Hee Kim, et al.
Vaccine|January 27, 2009
Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humansJoshua M DiNapoli, Jerrold M Ward, Lily Cheng, et al.
Molecular & Cellular Proteomics : MCP|August 10, 2014
A comprehensive proteomic view of responses of A549 type II alveolar epithelial cells to human respiratory syncytial virus infectionKeyur A Dave, Emma L Norris, Alexander A Bukreyev, et al.
Vaccine|October 28, 2009
A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidatesEmmalene J Bartlett, Ann-Marie Cruz, Jim Boonyaratanakornkit, et al.
Pageof 25